Hjem › Ikke-småcellet lungekreft › Arizona › Scottsdale
Kliniske studier for Ikke-småcellet lungekreft i Scottsdale, AZ
15 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Scottsdale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Ironwood Cancer & Research Centers, Scottsdale
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- HonorHealth Research Institute, Scottsdale
A Study of KK2269 in Adult Participants With Solid Tumors
RekruttererFase 1
- Mayo Clinic Arizona, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruttererFase 1
- HonorHealth, Scottsdale
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
RekruttererFase 1
- HonorHealth Research Institute, Scottsdale
- Mayo Scottsdale, Scottsdale
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
AOH1996 for the Treatment of Refractory Solid Tumors
RekruttererFase 1
- Honor Health Research and Innovation Institute, Scottsdale
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekruttererFase 1
- Mayo Clinic, Scottsdale
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Research Site, Scottsdale
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- Mayo Clinic Scottsdale, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Scottsdale
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekruttererFase 1
- HonorHealth Research Institute, Scottsdale
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Scottsdale
- Brystkreft18 studier
- Kreft (alle typer)18 studier
- Metastatisk kreft17 studier
- Prostatakreft17 studier
- Kolorektal kreft16 studier
- Pankreaskreft13 studier
- Melanom10 studier
- Ulcerøs kolitt8 studier
- Lungekreft8 studier
- Leverkreft (hepatocellulært karcinom)7 studier
- Alzheimers sykdom7 studier
- Tripelnegativ brystkreft7 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.